Actinobac Biomed

Healthcare 📍 North Brunswick, United States 👥 11-50 employees 💰 $600K raised 📅 Founded 2009

Actinobac Biomed focuses on the development of pharmaceutical technologies derived from agents that target Leukocyte Function Antigen-1 (LFA-1). The company's lead product, Leukotoxin, is a bacterial toxin that specifically targets white blood cells. In addition to its use as an effective targeted therapy agent for t

🌐 Website in LinkedIn ← All Companies

📊 Company Overview

Sector

Healthcare

Country

United States

Employees

11-50

Total Raised · Venture

$600K

Founded

2009

Cloud

Unknown

CDN

Cloudflare

☁️ Cloud Infrastructure

🔒 Subscribers only Cloud Provider

Behind Cloudflare — actual host undetectable

Workspace	🔒 Subscribers only
CDN	Cloudflare

Detected via DNS records and HTTP response headers as of 2026-06-13.

💰 Estimated Cloud Spend

$108K – $270K / year across cloud providers

🛠 Tech Stack & Marketing

Ad Platforms	🔒 Subscribers only
Analytics & CRM	🔒 Subscribers only
CMS / Platform	🔒 Subscribers only
Frontend Stack	🔒 Subscribers only

Detected from Actinobac Biomed's public homepage as of 2026-06-13.

🔍 Compare with Similar Companies

Same sector (Healthcare), similar size

1-10 ☁️ Unknown

Central Printing Group

1-10 ☁️ Unknown

Ortho Clinical Diagnostics Holdings Plc

1-10 ☁️ Azure

Data detected 2026-06-13 · Methodology · Suggest a correction